Related Experiment Video
Updated: Jan 7, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
The Effect of Proton Pump Inhibitors on Bone Mineral Density at Specific Anatomical Sites: A Systematic Review and
Areeg Anwer Ali1, Bhoomendra A Bhongade2, Fatima Mohamed Alkaabi1
1Department of Clinical Pharmacy and Pharmacology, RAK College of Pharmacy, Ras Al Khaimah Medical & Health Sciences University, Ras Al Khaimah, UAE.
Abstract:
There have been some concerns about the potential adverse consequences of proton pump inhibitors (PPIs) on bone health, specifically with respect to bone mineral density (BMD). The objective of the present investigation was to evaluate the impact of PPIs on BMD in the lumbar spine, femoral neck, and total hip regions. On the basis of PRISMA, a systematic review and meta-analysis were performed. PubMed, Scopus, Cochrane Library, and Google Scholar were used to find eligible observational studies published between January 2010 and January 2025. The ROBINS-I tool was employed to evaluate potential for bias, and studies with critical bias were excluded. To synthesize the data, random-effects models were utilized, and the I 2 statistic was used to evaluate heterogeneity. The sensitivity analyses and publication bias were also performed. A systematic review and quantitative synthesis used 20 and seven records, respectively, of 170 records screened. The comprehensive pooled analysis revealed that the decrease in BMD with the use of PPIs was modest yet statistically significant (SMD -0.15, 95% CI -0.21 to 0.09) alongside a substantial degree of heterogeneity (I 2 = 93.6%). Subgroup analysis demonstrated that there were significant decreases at the femoral neck (SMD -0.27, 95% CI -0.46 to -0.09), but not at the lumbar spine or the total hip. The funnel plot analysis indicated a certain level of asymmetry, and the sensitivity analysis indicated that the results were mostly robust; unless the study that excluded one outlier was used in the analysis, then the lumbar spine results would change. The use of PPIs is related to a significant but relatively small decrease in BMD, most obvious at the femoral neck, although findings across anatomical locations are heterogeneous. The results of this study support the cautious use of PPIs in all people at risk of osteoporosis and the need to conduct a high-quality prospective study to understand site-specific effects in the future.
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

